Login / Signup

Success of the US Veterans Health Administration's Hepatitis C Virus Care Continuum in the Direct-acting Antiviral Era.

Cara D VarleyElliott LowyEmily J CartwrightTimothy R MorganDavid B RossKarine Rozenberg-Ben-DrorLauren A BesteMarissa M Maier
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
The Veterans Health Administration has treated 80% of Veterans with hepatitis C in care 2021-2022 and achieved sustained virologic response in more than 90% of those treated. Repeat viremia is rare and is associated with younger age, unstable housing, opioid use, and stimulant use. Ongoing efforts are needed to reach younger Veterans, and Veterans with unstable housing or substance use disorders.
Keyphrases